PMC review on BPC-157 and wound healing
While there were reported improvements in non-motor symptom scores for the 600 mg/day treatment group, no statistically significant changes in motor symptoms were observed when compared to placebo
Within the broader catalogue, Semax's neurotrophin and neuromodulatory research applications provide a CNS-focused perspective that is mechanistically distinct from every other compound: the tissue repair biology of BPC-157 and TB-500, the extracellular matrix and genomic remodelling of GHK-Cu, the mitochondrial metabolism of MOTS-c, the triple hormonal agonism of retatrutide, the intracellular NAD+ biology of 5-Amino-1MQ, the endocrine axes of HGH, tesamorelin, CJC-1295 No DAC, ipamorelin, and HCG, and the GABAergic anxiolytic profile of Selank
For instance, Alabamas medical regulator recently issued a warning against the use of non-FDA-approved research-grade peptides due to health and safety risks